Search
Press release
Personal Care
January 11, 2010

New Head of the Care Specialties business unit of Evonik

As of January 1, 2010 Dr. Dietmar Moll, previously head of the Skin Care Product Line of Evonik Stockhausen GmbH, has taken charge of the Care Specialties business line of Evonik.

After completing his studies in nutritional and food sciences, Dr. Dietmar Moll embarked on his professional career in 1986 as a technical advisor for pesticide customer service at the Detia Group. In 1989, he moved to the research and application technology unit of the Enzymes division at Evonik Röhm GmbH in Darmstadt. Here, he subsequently served as head of product management for Enzyme technology, Head of marketing & sales for Pharma Polymers, and eventually head of the Pharma Polymers business unit. From 2001 to September 2006, he directed the Pharma Polymers business line within the Specialty Acrylics business unit, before being responsible for the Skin Care Product Line.

Company information

Evonik Industries is the creative industrial group from Germany which operates in three business areas: Chemicals, Energy and Real Estate. Evonik is a global leader in specialty chemicals, an expert in power generation from hard coal and renewable energies, and one of the largest private residential real estate companies in Germany. Our strengths are creativity, specialization, continuous self-renewal, and reliability.
Evonik is active in over 100 countries around the world. In its fiscal year 2008 about 41,000 employees generated sales of about €15.9 billion and an operat- ing profit EBITDA of about €2.2 billion.

Disclaimer

In so far as forecasts or expectations are expressed in this press release or where our statements concern the future, these forecasts, expectations or statements may involve known or unknown risks and uncertainties. Actual results or developments may vary, depending on changes in the operating environment. Neither Evonik Industries AG nor its group companies assume an obligation to update the forecasts, expectations or statements contained in this release.